{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T05:47:37Z","timestamp":1751953657926},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"DOI":"10.7759\/cureus.70642","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T17:30:23Z","timestamp":1727803823000},"source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic Potential of Fecal Microbiota Transplantation in Type 2 Diabetes Mellitus: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Muhammad Rizwan","family":"Aslam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alekya","family":"Perala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annetta V","family":"Wishart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranim K","family":"Hamouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Entesar","family":"Elsaady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safeera","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050. a systematic analysis for the Global Burden of Disease Study. (2021). Accessed: July 11, 2024: https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-673601301-6\/fulltext."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dci23-0085","article-title":"Economic costs of diabetes in the U.S. in 2022","volume":"47","author":"Parker ED","year":"2024","unstructured":"Parker ED, Lin J, Mahoney T, et al.. Economic costs of diabetes in the U.S. in 2022. Diabetes Care. 2024, 47:26-43. 10.2337\/dci23-0085","journal-title":"Diabetes Care"},{"key":"ref3","unstructured":"How many people in the UK have diabetes? Diabetes UK. (2024). Accessed. July 11, 2024: https:\/\/www.diabetes.org.uk\/about-us\/about-the-charity\/our-strategy\/statistics."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01516-6","article-title":"Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management","volume":"21","author":"Ma CX","year":"2022","unstructured":"Ma CX, Ma XN, Guan CH, Li YD, Mauricio D, Fu SB. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol. 2022, 21:74. 10.1186\/s12933-022-01516-6","journal-title":"Cardiovasc Diabetol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73668-y","article-title":"A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time","volume":"10","author":"Bjornsdottir HH","year":"2020","unstructured":"Bjornsdottir HH, Rawshani A, Rawshani A, Franz\u00e9n S, Svensson AM, Sattar N, Gudbj\u00f6rnsdottir S. A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time. Sci Rep. 2020, 10:17376. 10.1038\/s41598-020-73668-y","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2015.01.003","article-title":"The role of the gut microbiome in the healthy adult status","volume":"451","author":"D'Argenio V","year":"2015","unstructured":"D'Argenio V, Salvatore F. The role of the gut microbiome in the healthy adult status. Clin Chim Acta. 2015, 451:97-102. 10.1016\/j.cca.2015.01.003","journal-title":"Clin Chim Acta"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316155","article-title":"Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial","volume":"68","author":"Heianza Y","year":"2019","unstructured":"Heianza Y, Sun D, Li X, DiDonato JA, Bray GA, Sacks FM, Qi L. Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial. Gut. 2019, 68:263-70. 10.1136\/gutjnl-2018-316155","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin J","year":"2012","unstructured":"Qin J, Li Y, Cai Z, et al.. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012, 490:55-60. 10.1038\/nature11450","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/nu14010166","article-title":"Gut microbiota and complications of type-2 diabetes","volume":"14","author":"Iatcu CO","year":"2021","unstructured":"Iatcu CO, Steen A, Covasa M. Gut microbiota and complications of type-2 diabetes. Nutrients. 2021, 14:166. 10.3390\/nu14010166","journal-title":"Nutrients"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2022-003282","article-title":"Fecal microbiota transplantation ameliorates type 2 diabetes via metabolic remodeling of the gut microbiota in db\/db mice","volume":"11","author":"Chen L","year":"2023","unstructured":"Chen L, Guo L, Feng S, et al.. Fecal microbiota transplantation ameliorates type 2 diabetes via metabolic remodeling of the gut microbiota in db\/db mice. BMJ Open Diabetes Res Care. 2023, 11:e003282. 10.1136\/bmjdrc-2022-003282","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-019-0330-9","article-title":"Fecal microbiota transplantation improves metabolism and gut microbiome composition in db\/db mice","volume":"41","author":"Zhang PP","year":"2020","unstructured":"Zhang PP, Li LL, Han X, Li QW, Zhang XH, Liu JJ, Wang Y. Fecal microbiota transplantation improves metabolism and gut microbiome composition in db\/db mice. Acta Pharmacol Sin. 2020, 41:678-85. 10.1038\/s41401-019-0330-9","journal-title":"Acta Pharmacol Sin"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00455","article-title":"Promising treatment for type 2 diabetes: fecal microbiota transplantation reverses insulin resistance and impaired islets","volume":"9","author":"Wang H","year":"2019","unstructured":"Wang H, Lu Y, Yan Y, et al.. Promising treatment for type 2 diabetes: fecal microbiota transplantation reverses insulin resistance and impaired islets. Front Cell Infect Microbiol. 2019, 9:455. 10.3389\/fcimb.2019.00455","journal-title":"Front Cell Infect Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.09.008","article-title":"Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition","volume":"26","author":"Kootte RS","year":"2017","unstructured":"Kootte RS, Levin E, Saloj\u00e4rvi J, et al.. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab. 2017, 26:611-9.e6. 10.1016\/j.cmet.2017.09.008","journal-title":"Cell Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323617","article-title":"Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial","volume":"71","author":"Ng SC","year":"2022","unstructured":"Ng SC, Xu Z, Mak JW, et al.. Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial. Gut. 2022, 71:716-23. 10.1136\/gutjnl-2020-323617","journal-title":"Gut"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1089991","article-title":"Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: a randomized, controlled, prospective study","volume":"12","author":"Wu Z","year":"2022","unstructured":"Wu Z, Zhang B, Chen F, et al.. Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: a randomized, controlled, prospective study. Front Cell Infect Microbiol. 2022, 12:1089991. 10.3389\/fcimb.2022.1089991","journal-title":"Front Cell Infect Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.820367","article-title":"Prospective study reveals host microbial determinants of clinical response to fecal microbiota transplant therapy in type 2 diabetes patients","volume":"12","author":"Ding D","year":"2022","unstructured":"Ding D, Yong H, You N, et al.. Prospective study reveals host microbial determinants of clinical response to fecal microbiota transplant therapy in type 2 diabetes patients. Front Cell Infect Microbiol. 2022, 12:820367. 10.3389\/fcimb.2022.820367","journal-title":"Front Cell Infect Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05127-9","article-title":"Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation","volume":"12","author":"Su L","year":"2022","unstructured":"Su L, Hong Z, Zhou T, et al.. Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation. Sci Rep. 2022, 12:1152. 10.1038\/s41598-022-05127-9","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.985636","article-title":"Washed microbiota transplantation improves patients with high blood glucose in South China","volume":"13","author":"Wu L","year":"2022","unstructured":"Wu L, Li MQ, Xie YT, et al.. Washed microbiota transplantation improves patients with high blood glucose in South China. Front Endocrinol (Lausanne). 2022, 13:985636. 10.3389\/fendo.2022.985636","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105143","article-title":"Trust the gut: Outcomes of gut microbiota transplant in metabolic and cognitive disorders","volume":"149","author":"Guzzardi MA","year":"2023","unstructured":"Guzzardi MA, La Rosa F, Iozzo P. Trust the gut: Outcomes of gut microbiota transplant in metabolic and cognitive disorders. Neurosci Biobehav Rev. 2023, 149:105143. 10.1016\/j.neubiorev.2023.105143","journal-title":"Neurosci Biobehav Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0288718","article-title":"Effects of fecal microbiota transplantation in metabolic syndrome: a meta-analysis of randomized controlled trials","volume":"18","author":"Qiu B","year":"2023","unstructured":"Qiu B, Liang J, Li C. Effects of fecal microbiota transplantation in metabolic syndrome: a meta-analysis of randomized controlled trials. PLoS One. 2023, 18:e0288718. 10.1371\/journal.pone.0288718","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013543","article-title":"Fecal microbiota transplantation relieve painful diabetic neuropathy: a case report","volume":"97","author":"Cai TT","year":"2018","unstructured":"Cai TT, Ye XL, Yong HJ, et al.. Fecal microbiota transplantation relieve painful diabetic neuropathy: a case report. Medicine (Baltimore). 2018, 97:e13543. 10.1097\/MD.0000000000013543","journal-title":"Medicine (Baltimore)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1764309","article-title":"Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics","volume":"11","author":"Ka\u017amierczak-Siedlecka K","year":"2020","unstructured":"Ka\u017amierczak-Siedlecka K, Daca A, Fic M, van de Wetering T, Folwarski M, Makarewicz W. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics. Gut Microbes. 2020, 11:1518-30. 10.1080\/19490976.2020.1764309","journal-title":"Gut Microbes"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01126-6","article-title":"Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db\/db mice","volume":"9","author":"Zhuang P","year":"2021","unstructured":"Zhuang P, Li H, Jia W, et al.. Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db\/db mice. Microbiome. 2021, 9:185. 10.1186\/s40168-021-01126-6","journal-title":"Microbiome"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/nature18309","article-title":"Acetate mediates a microbiome-brain-\u03b2-cell axis to promote metabolic syndrome","volume":"534","author":"Perry RJ","year":"2016","unstructured":"Perry RJ, Peng L, Barry NA, et al.. Acetate mediates a microbiome-brain-\u03b2-cell axis to promote metabolic syndrome. Nature. 2016, 534:213-7. 10.1038\/nature18309","journal-title":"Nature"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/278363-therapeutic-potential-of-fecal-microbiota-transplantation-in-type-2-diabetes-mellitus-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T17:30:25Z","timestamp":1727803825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/278363-therapeutic-potential-of-fecal-microbiota-transplantation-in-type-2-diabetes-mellitus-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.70642","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}